Clinical trial
A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate…
NCT00473512 · Cougar Biotechnology, Inc., Industry · Completed
Key facts
| NCT number | NCT00473512 |
|---|---|
| Title | A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy |
| Official title | A Phase I/II Open Label Study of the 17α-Hydroxylase/ C17,20 Lyase Inhibitor, Abiraterone Acetate in Patients With Prostate Cancer Who Have Failed Hormone Therapy |
| Lead sponsor | Cougar Biotechnology, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Drug |
| Interventions | Abiraterone acetate, Abiraterone acetate MTD, Dexamethasone |
| Enrollment | 54 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 15, 2007 |
| Last update posted | Mar 27, 2014 |
| Countries | United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: